Nuclear medicine and biology

Keyphrases

Publications

2024

Xiaohui Zhang, Lin Qiu, Debbie H Sultan, Hannah P Luehmann, Yanbo Yu, Xiuli Zhang, Gyu Seong Heo, Alexandria Li, Divangana Lahad, Shinji Rho, Zhude Tu, Yongjian Liu
Development of a CCR2 targeted 18 F-labeled radiotracer for atherosclerosis imaging with PET. Nuclear medicine and biology (2024)
Bryce J B Nelson, Samantha Leier, John Wilson, Melinda Wuest, Jonathan Doupe, Jan D Andersson, Frank Wuest
64 Cu production via the 68 Zn(p,nα) 64 Cu nuclear reaction: An untapped, cost-effective and high energy production route. Nuclear medicine and biology (2024)
Ivan E Wang, Allen F Brooks, Mara Clark, Luke J Morrissette, Peter J H Scott
Improved purification of cyclotron [ 68 Ga]GaCl 3 for the production of 68 Ga radiopharmaceuticals. Nuclear medicine and biology (2024)
Alexia Kirby, Mojmír Suchý, Daniel Duan, Mark Bazett, Shirin Kalyan, Adam J Shuhendler
Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography. Nuclear medicine and biology (2024)
Amina Khalil, Sona Hakhverdyan, Pierre Cheung, Martin Bossart, Michael Wagner, Olof Eriksson, Irina Velikyan
Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor. Nuclear medicine and biology (2024)
Ivan E Wang, Allen F Brooks, Mara Clark, Luke J Morrissette, Peter J H Scott
Improved purification of cyclotron [ 68 Ga]GaCl 3 for the production of 68 Ga radiopharmaceuticals. Nuclear medicine and biology (2024)
Michael R Dyer, Zhenghan Jing, Kathleen Duncan, Jacqueline Godbe, Monica Shokeen
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases. Nuclear medicine and biology (2024)
Muriel Aline Spahn, Kaat Luyten, Tom Van Loy, Mike Sathekge, Christophe M Deroose, Michel Koole, Dominique Schols, Wim Vanduffel, Kristof De Vos, Pieter Annaert, Guy Bormans, Frederik Cleeren
Second generation Al 18 F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging. Nuclear medicine and biology (2024)
Bryce J B Nelson, Samantha Leier, John Wilson, Melinda Wuest, Jonathan Doupe, Jan D Andersson, Frank Wuest
64 Cu production via the 68 Zn(p,nα) 64 Cu nuclear reaction: An untapped, cost-effective and high energy production route. Nuclear medicine and biology (2024)
Anders Josefsson, Angel G Cortez, Jing Yu, Sunipa Majumdar, Abhinav Bhise, Robert F Hobbs, Jessie R Nedrow
Evaluation of targeting α V β 3 in breast cancers using RGD peptide-based agents. Nuclear medicine and biology (2024)
Shohei Tsuchihashi, Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation. Nuclear medicine and biology (2024)
Anders Josefsson, Angel G Cortez, Jing Yu, Sunipa Majumdar, Abhinav Bhise, Robert F Hobbs, Jessie R Nedrow
Evaluation of targeting α V β 3 in breast cancers using RGD peptide-based agents. Nuclear medicine and biology (2024)
Lukáš Ondrák, Kateřina Ondrák Fialová, Michal Sakmár, Martin Vlk, Frank Bruchertseifer, Alfred Morgenstern, Ján Kozempel
Development of 225 Ac/ 213 Bi generator based on α-ZrP-PAN composite for targeted alpha therapy. Nuclear medicine and biology (2024)
Cassis Varlow, Chester A Mathis, Neil Vasdev
In vitro evaluation of [ 3 H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies. Nuclear medicine and biology (2024)
Ida Vang Andersen, Natasha Shalina Rajani Bidesi, Vladimir Shalgunov, Jesper Tranekjær Jørgensen, Tobias Gustavsson, Kristian Strømgaard, Andreas T Ingemann Jensen, Andreas Kjær, Matthias M Herth
Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin - A feasibility study using positron emission tomography and [ 64 Cu]Cu-DOTATATE. Nuclear medicine and biology (2024)
Yuli Sun, Guangwen Li, Haiyan Hong, Lin Zhu, Hank F Kung, Yan Zhang, Jinxia Zhu
Serotonin transporter imaging agent as a probe for β-cells of pancreas. Nuclear medicine and biology (2024)
Xiaohui Zhang, Lin Qiu, Debbie H Sultan, Hannah P Luehmann, Yanbo Yu, Xiuli Zhang, Gyu Seong Heo, Alexandria Li, Divangana Lahad, Shinji Rho, Zhude Tu, Yongjian Liu
Development of a CCR2 targeted 18 F-labeled radiotracer for atherosclerosis imaging with PET. Nuclear medicine and biology (2024)
Xiaohui Zhang, Lin Qiu, Debbie H Sultan, Hannah P Luehmann, Yanbo Yu, Xiuli Zhang, Gyu Seong Heo, Alexandria Li, Divangana Lahad, Shinji Rho, Zhude Tu, Yongjian Liu
Development of a CCR2 targeted 18 F-labeled radiotracer for atherosclerosis imaging with PET. Nuclear medicine and biology (2024)
Michal Sakmár, Ján Kozempel, Jan Kučka, Tereza Janská, Matěj Štíbr, Martin Vlk, Luděk Šefc
Biodistribution study of 211 Pb progeny released from intravenously applied 223 Ra labelled TiO 2 nanoparticles in a mouse model. Nuclear medicine and biology (2024)
Vladimir Shalgunov, Sara Lopes van den Broek, Ida Vang Andersen, Nakul R Raval, Gabriela Schäfer, Matthias Barz, Matthias M Herth, Umberto M Battisti
Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[ 18 F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine. Nuclear medicine and biology (2024)
Anders Josefsson, Angel G Cortez, Jing Yu, Sunipa Majumdar, Abhinav Bhise, Robert F Hobbs, Jessie R Nedrow
Evaluation of targeting α V β 3 in breast cancers using RGD peptide-based agents. Nuclear medicine and biology (2024)
Hsin-Hua Hsieh, Pei-An Chu, Yu-Hsin Lin, Yu-Chieh Jill Kao, Yi-Hsiu Chung, Shih-Ting Hsu, Jia-Min Mo, Chun-Yi Wu, Shin-Lei Peng
Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18 F-FEPPA PET. Nuclear medicine and biology (2024)
Michal Sakmár, Ján Kozempel, Jan Kučka, Tereza Janská, Matěj Štíbr, Martin Vlk, Luděk Šefc
Biodistribution study of 211 Pb progeny released from intravenously applied 223 Ra labelled TiO 2 nanoparticles in a mouse model. Nuclear medicine and biology (2024)
Michael R Dyer, Zhenghan Jing, Kathleen Duncan, Jacqueline Godbe, Monica Shokeen
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases. Nuclear medicine and biology (2024)
Bryce J B Nelson, Samantha Leier, John Wilson, Melinda Wuest, Jonathan Doupe, Jan D Andersson, Frank Wuest
64 Cu production via the 68 Zn(p,nα) 64 Cu nuclear reaction: An untapped, cost-effective and high energy production route. Nuclear medicine and biology (2024)
Hiroyuki Suzuki, Masato Matsukawa, Rikako Madokoro, Yui Terasaka, Kento Kannaka, Tomoya Uehara
Reduction of the hepatic radioactivity levels of [ 111 In]In-DOTA-labeled antibodies via cleavage of a linkage metabolized in lysosomes. Nuclear medicine and biology (2024)
Amina Khalil, Sona Hakhverdyan, Pierre Cheung, Martin Bossart, Michael Wagner, Olof Eriksson, Irina Velikyan
Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor. Nuclear medicine and biology (2024)
Chanelle Hunter, Benjamin Larimer
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications. Nuclear medicine and biology (2024)
Suzanne E Lapi, Peter J H Scott
The future of the radiopharmaceutical sciences. Nuclear medicine and biology (2024)
Yutian Feng, Rebecca L Meshaw, Sean W Finch, Yongxiang Zheng, Il Minn, Ganesan Vaidyanathan, Martin G Pomper, Michael R Zalutsky
A third generation PSMA-targeted agent [ 211 At]YF2: Synthesis and in vivo evaluation. Nuclear medicine and biology (2024)
Xiaohui Zhang, Lin Qiu, Debbie H Sultan, Hannah P Luehmann, Yanbo Yu, Xiuli Zhang, Gyu Seong Heo, Alexandria Li, Divangana Lahad, Shinji Rho, Zhude Tu, Yongjian Liu
Development of a CCR2 targeted 18 F-labeled radiotracer for atherosclerosis imaging with PET. Nuclear medicine and biology (2024)
Xiaohui Zhang, Lin Qiu, Debbie H Sultan, Hannah P Luehmann, Yanbo Yu, Xiuli Zhang, Gyu Seong Heo, Alexandria Li, Divangana Lahad, Shinji Rho, Zhude Tu, Yongjian Liu
Development of a CCR2 targeted 18 F-labeled radiotracer for atherosclerosis imaging with PET. Nuclear medicine and biology (2024)
Yuli Sun, Guangwen Li, Haiyan Hong, Lin Zhu, Hank F Kung, Yan Zhang, Jinxia Zhu
Serotonin transporter imaging agent as a probe for β-cells of pancreas. Nuclear medicine and biology (2024)
Truc T Huynh, Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Lior Rosenfeld, Ganesan Vaidyanathan, Niv Papo, Michael R Zalutsky
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics. Nuclear medicine and biology (2024)
Ivan E Wang, Allen F Brooks, Mara Clark, Luke J Morrissette, Peter J H Scott
Improved purification of cyclotron [ 68 Ga]GaCl 3 for the production of 68 Ga radiopharmaceuticals. Nuclear medicine and biology (2024)
Cassis Varlow, Chester A Mathis, Neil Vasdev
In vitro evaluation of [ 3 H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies. Nuclear medicine and biology (2024)
Michal Sakmár, Ján Kozempel, Jan Kučka, Tereza Janská, Matěj Štíbr, Martin Vlk, Luděk Šefc
Biodistribution study of 211 Pb progeny released from intravenously applied 223 Ra labelled TiO 2 nanoparticles in a mouse model. Nuclear medicine and biology (2024)
Michael R Dyer, Zhenghan Jing, Kathleen Duncan, Jacqueline Godbe, Monica Shokeen
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases. Nuclear medicine and biology (2024)
Cassis Varlow, Chester A Mathis, Neil Vasdev
In vitro evaluation of [ 3 H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies. Nuclear medicine and biology (2024)
Mohini Guleria, K J Pallavi, Pranjal P Gujarathi, Tapas Das
Evaluation of acute intravenous toxicity of HEPES: Is Good's buffer good and safe enough for clinical utilization in nuclear medicine? Nuclear medicine and biology (2024)
Xiaohui Zhang, Lin Qiu, Debbie H Sultan, Hannah P Luehmann, Yanbo Yu, Xiuli Zhang, Gyu Seong Heo, Alexandria Li, Divangana Lahad, Shinji Rho, Zhude Tu, Yongjian Liu
Development of a CCR2 targeted 18 F-labeled radiotracer for atherosclerosis imaging with PET. Nuclear medicine and biology (2024)
Sabeena Giri, Kevin J H Allen, Chandra Bose Prabaharan, Jonathan Bonet Ramirez, Luciano Fiore, Maruti Uppalapati, Ekaterina Dadachova
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma. Nuclear medicine and biology (2024)
Amina Khalil, Sona Hakhverdyan, Pierre Cheung, Martin Bossart, Michael Wagner, Olof Eriksson, Irina Velikyan
Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor. Nuclear medicine and biology (2024)
Hsin-Hua Hsieh, Pei-An Chu, Yu-Hsin Lin, Yu-Chieh Jill Kao, Yi-Hsiu Chung, Shih-Ting Hsu, Jia-Min Mo, Chun-Yi Wu, Shin-Lei Peng
Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18 F-FEPPA PET. Nuclear medicine and biology (2024)
Tetsuro Tada, Yuki Mizuno, Yuki Shibata, Hironobu Yasui, Yuji Kuge
Application of copper (I) selective ligands for PET imaging of reactive oxygen species through metabolic trapping. Nuclear medicine and biology (2024)
Kaixin Qin, Dongmei Shi, Yuzhou Zheng, Wenhao Hu, Xiameng Kang, Ping Wu, Xinzhong Hao, Haiyan Liu, Jie Gao, Jianguo Li, Zhifang Wu, Sijin Li, Hongliang Wang
Synthesis and evaluation of a 68 Ga-labeled spermine derivative for tumor PET imaging. Nuclear medicine and biology (2024)
Yuli Sun, Guangwen Li, Haiyan Hong, Lin Zhu, Hank F Kung, Yan Zhang, Jinxia Zhu
Serotonin transporter imaging agent as a probe for β-cells of pancreas. Nuclear medicine and biology (2024)
Vladimir Shalgunov, Sara Lopes van den Broek, Ida Vang Andersen, Nakul R Raval, Gabriela Schäfer, Matthias Barz, Matthias M Herth, Umberto M Battisti
Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[ 18 F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine. Nuclear medicine and biology (2024)
Hsin-Hua Hsieh, Pei-An Chu, Yu-Hsin Lin, Yu-Chieh Jill Kao, Yi-Hsiu Chung, Shih-Ting Hsu, Jia-Min Mo, Chun-Yi Wu, Shin-Lei Peng
Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18 F-FEPPA PET. Nuclear medicine and biology (2024)
Vladimir Shalgunov, Sara Lopes van den Broek, Ida Vang Andersen, Nakul R Raval, Gabriela Schäfer, Matthias Barz, Matthias M Herth, Umberto M Battisti
Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[ 18 F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine. Nuclear medicine and biology (2024)